Stock 603520 ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Starry Pharmaceutical Co.,Ltd.

Equities

603520

CNE1000026N8

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
11.87 CNY +0.17% Intraday chart for Zhejiang Starry Pharmaceutical Co.,Ltd. +9.00% -15.70%
2023 Zhejiang Starry Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
2023 Zhejiang Starry Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 3,166 7,125 16,099 15,886 6,694 4,066 4,066 -
Enterprise Value (EV) 1 3,166 7,125 16,099 15,886 6,694 4,066 4,066 4,066
P/E ratio 33.8 x 42.1 x 65.8 x 49.2 x -89 x 35.8 x 14.5 x 9.33 x
Yield - - 0.76% 0.77% 1.02% 0.97% 2.11% 2.95%
Capitalization / Revenue 3.55 x 5.44 x 11.8 x 7.94 x 3.14 x 1.67 x 1.4 x 1.19 x
EV / Revenue 3.55 x 5.44 x 11.8 x 7.94 x 3.14 x 1.67 x 1.4 x 1.19 x
EV / EBITDA 14.8 x 20.8 x 38.1 x 28.4 x 59.1 x 8.3 x 6.17 x 5 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 3.55 x 7.17 x 8.84 x 7.32 x 3.8 x 2.19 x 1.91 x 1.59 x
Nbr of stocks (in thousands) 329,280 328,583 342,369 342,150 342,040 342,515 342,515 -
Reference price 2 9.614 21.68 47.02 46.43 19.57 11.87 11.87 11.87
Announcement Date 3/25/19 3/30/20 4/27/21 4/25/22 4/17/23 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 890.5 1,309 1,367 2,000 2,131 2,437 2,912 3,429
EBITDA 1 214.2 342.4 423 558.9 113.2 489.6 658.6 812.7
EBIT 1 126.8 230.3 293.9 399.8 -55.79 133.9 314.5 475.2
Operating Margin 14.24% 17.6% 21.5% 19.99% -2.62% 5.49% 10.8% 13.86%
Earnings before Tax (EBT) 1 118.7 221.9 303.7 395.4 -65.4 129 311 469.9
Net income 1 93.68 170.3 238.7 323.8 -75.85 114.3 280.5 435.8
Net margin 10.52% 13.01% 17.46% 16.19% -3.56% 4.69% 9.63% 12.71%
EPS 2 0.2843 0.5153 0.7143 0.9429 -0.2200 0.3320 0.8180 1.272
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - 0.3571 0.3571 0.2000 0.1150 0.2500 0.3500
Announcement Date 3/25/19 3/30/20 4/27/21 4/25/22 4/17/23 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 10.8% 18% 17.7% 16% -3.81% 6.16% 13.3% 17.2%
ROA (Net income/ Total Assets) - - 6.05% 6.96% -1.49% 3.8% 5% -
Assets 1 - - 3,945 4,651 5,097 3,007 5,610 -
Book Value Per Share 2 2.710 3.030 5.320 6.340 5.150 5.410 6.210 7.450
Cash Flow per Share 2 0.5800 0.7500 0.5100 1.480 -0.2300 1.240 1.440 1.560
Capex 1 162 132 139 297 471 514 584 450
Capex / Sales 18.24% 10.08% 10.18% 14.83% 22.08% 21.07% 20.05% 13.12%
Announcement Date 3/25/19 3/30/20 4/27/21 4/25/22 4/17/23 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Zhejiang Starry Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.87
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD. Stock Zhejiang Starry Pharmaceutical Co.,Ltd.
-15.70% 561M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603520 Stock
  4. Financials Zhejiang Starry Pharmaceutical Co.,Ltd.